{
  "id": "238a6de590878f69",
  "title": "EQS - News : Secarna Pharmaceuticals GmbH & Co . KG : Secarna Pharmaceuticals and Protalix Biotherapeutics Enter into Collaboration and Option Agreement",
  "description": "20251217T121500Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2025-12/67254793-eqs-news-secarna-pharmaceuticals-gmbh-co-kg-secarna-pharmaceuticals-and-protalix-biotherapeutics-enter-into-collaboration-and-option-agreement-023.htm",
  "published_at": "20251217T121500Z",
  "fetched_at": "2025-12-18T00:22:47.263985+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2025-12/67254793-eqs-news-secarna-pharmaceuticals-gmbh-co-kg-secarna-pharmaceuticals-and-protalix-biotherapeutics-enter-into-collaboration-and-option-agreement-023.htm",
    "url_mobile": "",
    "title": "EQS - News : Secarna Pharmaceuticals GmbH & Co . KG : Secarna Pharmaceuticals and Protalix Biotherapeutics Enter into Collaboration and Option Agreement",
    "seendate": "20251217T121500Z",
    "socialimage": "https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2247192&application_name=news&site_id=finanznachrichten_de~~~9720c437-ed68-45dd-9c8b-6fe1cab594aa",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}